Baseline characteristics | |
---|---|
Age, years (mean ± SD) | 60 ± 9 |
Male, n (%) | 22 (71) |
BMI, kg/m2 (mean ± SD) | 27.6 ± 3.8 |
Hypertension, n (%) | 27 (87.1) |
Hyperlipidemia, n (%) | 29 (93.5) |
Diabetes mellitus | 9 (29.0) |
Smoking | 19 (61.3) |
Family history of cardiovascular disease, n (%) | 16 (51.6) |
Previous myocardial infarction, n (%) | 14 (45.2) |
Previous PCI, n (%) | 10 (32.3) |
Stress echocardiography test | |
• Positive, n (%) | 21 (67.7) |
• Negative, n (%) | 10 (32.3) |
Acetylsalicylic acid, n (%) | 31 (100) |
P2Y12 inhibitor, n (%) | 31 (100) |
ACE inhibitors, n (%) | 20 (64.5) |
ARBs, n (%) | 1 (3.2) |
Beta blockers, n (%) | 24 (77.4) |
Trimetazidine, n (%) | 13 (41.9) |
Long-acting nitrates, n (%) | 9 (29.0) |
CCBs, n (%) | 9 (29.0) |
Statins, n (%) | 25 (80.6) |
Diuretics, n (%) | 7 (22.6) |